Fierce Biotech August 26, 2024
Just days after gene editor Tome Biosciences announced undisclosed operational cuts, a clearer picture is coming into focus as 131 employees are being laid off.
The biotech, which emerged with $213 million late last year, will complete the layoffs by Nov. 1 to Nov. 14, according to a Massachusetts Worker Adjustment and Retraining Notification (WARN) report filed Friday.
Last Thursday, Tome CEO Rahul Kakkar told Endpoints News that the biotech had just over 130 staffers and that no layoffs were announced during a company-wide meeting earlier in the week.
“Despite our clear scientific progress, investor sentiment has shifted dramatically across the gene editing space, particularly for preclinical companies,” a Tome spokesperson told Fierce Biotech in an Aug. 22 emailed statement....
Today's Sponsors
Today's Sponsor